Bankruptcy trick is not an option for Bayer

Moderna scores with vaccine against RS virus

IPO still possible in 2023

Stock market week winners and losers

New omicron subline should become dominant

Investors are demanding a new CEO from outside

Biontech and Moderna in the expansion race

Investors are demanding a new CEO from outside

Activist funds target Bayer

Funds decide on measures against drug shortages